|
|
Article: CANTAB PHARMACEUTICALS INTENDS TO RAISE 25 MILLION POUNDS STERLING IN SECONDARY PUBLIC OFFERING
- Article from:
- PR Newswire
- Article date:
- May 14, 1996
CopyrightCOPYRIGHT 1996 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Offering to Be Made to Institutional
Investors Outside United States
CAMBRIDGE, England, May 14 /PRNewswire/ -- Cantab Pharmaceuticals plc (Nasdaq: CNTBY) today announced that it intends to raise approximately 25 million pounds sterling of new monies by way of a non pre-emptive Offering of new Cantab Common Shares to be listed on the London Stock Exchange to international institutional investors outside the United States. The Offering will be subject to Cantab Shareholder approval to disapply pre-emption rights at an Extraordinary General Meeting. The Offering is expected to be effective in June 1996.
As reported in ...